Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4/A Registration of securities issued in business combination transactions
- 4.1 Specimen Class a Common Stock Certificate
- 5.1 Opinion of White & Case LLP As to the Validity of the Securities Being Registered
- 8.1 Opinion of Reed Smith LLP Regarding Certain Federal Income Tax Matters
- 10.18 Amendment to Employment Agreement Between Somalogic, Inc. and Roy Smythe
- 10.19 Amendment to Employment Agreement Between Somalogic, Inc. and Stephen Williams
- 10.20 Amendment to Employment Agreement Between Somalogic, Inc. and Melody Harris
- 23.1 Consent of Withumsmith+brown, PC
- 23.2 Consent of Ernst & Young LLP
- 99.1 Form of Preliminary Proxy Card
- 99.5 Consent of Robert Barchi to Be Named As Director
- 99.6 Consent of Anne Margulies to Be Named As Director
- 99.7 Consent of Ted Meisel to Be Named As Director
- 99.8 Consent of Richard Post to Be Named As Director
Associated filings
- 13 Aug 21 EFFECT Notice of effectiveness
- 12 Aug 21 424B3 Prospectus supplement
- 5 Aug 21 S-4/A Registration of securities issued in business combination transactions (amended)
-
22 Jul 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 25 Jun 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 14 May 21 S-4 Registration of securities issued in business combination transactions
SLGCW similar filings
Filing view
External links
Exhibit 99.8
CONSENT TO REFERENCE IN PROXY STATEMENT/
PROSPECTUS
July 21, 2021
CM Life Sciences II Inc.
667 Madison Avenue
New York, New York
CM Life Sciences II Inc. (the “Company”) is filing a Registration Statement on Form S-4 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”). In connection therewith, I hereby consent, pursuant to Rule 438 of the Securities Act, to the reference to me in the proxy statement/prospectus included in such Registration Statement as a future member of the board of directors of the Company, such appointment to commence immediately after the effective time of the merger described in the proxy statement/prospectus.
Sincerely, | |
/s/ Richard Post | |
Richard Post |